No Data
No Data
Investors Can Find Comfort In Walvax Biotechnology's (SZSE:300142) Earnings Quality
Walvax Biotechnology (SZSE:300142) Seems To Use Debt Quite Sensibly
Watson Biotech: Q3 2024 Report
Walvax Biotechnology (300142.SZ) released its performance for the first three quarters, with a net income of 0.256 billion yuan, a decrease of 53.67%.
Walvax Biotechnology (300142.SZ) released its third quarter report for 2024, with revenue for the first three quarters at 2...
Express News | Walvax Biotechnology Says Q3 Net Profit Down 12.6% Y/Y
Walvax Biotechnology Gets Nod to Market Pneumococcal Vaccine in Oman
No Data
No Data